SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-009978
Filing Date
2024-03-14
Accepted
2024-03-14 16:53:16
Documents
16
Period of Report
2024-03-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37074
2 ex10-1.htm EX-10.1 87504
3 ex10-1_001.jpg GRAPHIC 11438
  Complete submission text file 0001493152-24-009978.txt   322269

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnxt-20240314.xsd EX-101.SCH 3015
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnxt-20240314_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnxt-20240314_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3400
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 24751028
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)